Yanshu Li

Yanshu Li

Auto-generated profile, based on publicly available information

Yanshu Li

Chinese Academy of Sciences

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2020 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
XFXin Fu
Xin Fu
YLYan-Shu Li
Yan-Shu Li
JZJun Zhao
Jun Zhao
LYLu-Lu Yu
Lu-Lu Yu
RLRong-Guang Luo
Rong-Guang Luo
QTQun Tang
Qun Tang
Arsenic trioxide (ATO) has remarkably enhanced therapeutic efficacy in treating both newly diagnosed and relapsed patients suffering from Acute Promyelocytic Leukemia (APL). Unfortunately, whether as a single agent, component of combined chemotherapy, or as a chemosensitizer or radiosensitizer combined with interventional therapy/radiotherapy, it did not benefit treatment of solid tumor (liver cancer, bladder cancer, glioma, breast cancer, cervical cancer, colorectal cancer, lung cancer, and melanoma) as seen from the clinical trials reported from the published journals or FDA-approved trials in the past decades. The clinical outcome failed to live up to our expectations, which was attributed to severe systemic toxicity and inappropriate pharmacokinetic such as low delivery efficiency and rapid renal elimination. Nanomedicine is designed to fuel up pharmaceuticals and polish off adverse effects by the moderation of their absorption, distribution, metabolism, and excretion. Nevertheless, quite a few nanodrugs (such as Doxil, Abraxane) were approved to be used clinically, and “from bench to bedside” it seems to be no easy way for most of them, such as nano-ATO. Encapsulating ATO into several types of nano-vehicles (liposome, polymer micelle, porous silicon, etc.), nano-TO can improve pharmacokinetic and become a prominent candidate to penetrate into tumor tissue, but so far no nano- ATO clinical trials have been approved around the world. On summarizing the clinical trials of ATO on solid tumor and preclinical study of nano-ATO, it is believed there is still a chance for ATO to play a critical co-helper in a comprehensive therapy to fight with solid tumor.

1 January 2021 in International Journal of Biological Sciences
Verified
Journal Article
Open access
YXYao Xing
Yao Xing
YLYang Li
Yang Li
BHBingtao Hu
Bingtao Hu
FHFuyi Han
Fuyi Han
XZXin Zhao
Xin Zhao
FLFeng Li
Feng Li
Although p21 activated kinase 5 (PAK5) is related to the progression of multiple cancers, its biological function in breast cancer remains unclear. Apoptosis-inducing factor (AIF) is a vital apoptosis factor in mitochondria, which can be released from mitochondria and enter the nucleus, causing caspase-independent apoptosis. In this study, we reveal that PAK5 inhibits apoptosis by preventing the nuclear translocation of AIF. PAK5 inhibits the release of AIF from mitochondria in breast cancer cells by decreasing the mitochondria membrane permeability and increasing the membrane potential. Furthermore, PAK5 phosphorylates AIF at Thr281 site to inhibit the formation of AIF/importin α3 complex, leading to decrease AIF nuclear translocation. Functionally, we demonstrate that PAK5-mediated AIF phosphorylation promotes the proliferation of breast cancer cells and accelerates the growth of breast cancer in vivo. Significantly, PAK5 and AIF expression in breast cancer are positively correlated with poor patient prognosis. PAK5 expression is negatively correlated with AIF nuclear translocation. These results suggest that PAK5-AIF signaling pathway may play an essential role in mammary tumorigenesis, providing a new therapeutic target for the treatment of breast cancer.

15 November 2023
Verified
Book Chapter
Closed access
PDF file
HYHaitian Yang
Haitian Yang
DSDegang Sun
Degang Sun
WLWen Liu
Wen Liu
YLYanshu Li
Yanshu Li
YWYan Wang
Yan Wang
WHWeiqing Huang
Weiqing Huang

1 August 2021 in Journal of Physics: Conference Series
Verified
Conference Paper
Open access
YBYaodong Bao
Yaodong Bao
YLYanshu Li
Yanshu Li
JCJunshen Chen
Junshen Chen
This paper examines the impact of higher education on China’s manufacturing industry performance from the national and regional levels on fixed effects model. The research shows that the development of higher education has significantly promoted the improvement of China’s manufacturing industry performance. If the development of higher education increases by 1%, the performance of manufacturing industry will increase by 0.239%. Through the internal mechanism test, it is found that higher education can improve the performance of manufacturing industry by increasing the R&D projects, new product projects and enterprise invention patents. Further research shows that there is a double threshold nonlinear relationship between higher education and manufacturing industry performance with per capita GDP and government financial science and technology expenditure as threshold variables based on threshold model.

1 January 2023 in Journal of Physical Therapy Science
Verified
Journal Article
Open access
PDF file
Zijian LiuZijian Liu
Zijian Liu
TMToshihiro Maemichi
Toshihiro Maemichi
MMMasatomo Matsumoto
Masatomo Matsumoto
TOTakumi Okunuki
Takumi Okunuki
HTHirofumi Tanaka
Hirofumi Tanaka
Tsukasa KumaiTsukasa Kumai
Tsukasa Kumai
[Purpose] To measure the sub-sesamoid soft tissue thickness change from non-loading to self-weight loading conditions. [Participants and Methods] The study included 17 female participants for the study. A questionnaire was used to collect the demographic data and participant anamnesis, such as the presence of foot injuries and diabetes. The measured height and weight were used to calculate the body mass index. Participants were required to stand on an evaluation device from non-loading to 100% loading conditions to measure the sub-sesamoid soft tissue thickness. [Results] Significant differences were observed between the tibial and fibular sub-sesamoid soft tissue thicknesses under non-loading and all loading conditions. Significant soft tissue thinning was observed with a change from non-loading to 25% loading condition. However, no significant differences in the rate of change were observed between the tibial and fibular sub-sesamoid soft tissue thicknesses at 100% loading. [Conclusion] The sub-fibular sesamoid soft tissue was thicker than the sub-tibial sesamoid soft tissue in all loading conditions. The sub-sesamoid soft tissue thickness change was larger during initial loading stage than during the late loading stage, which may be normal in healthy females in their 20s.

23 August 2015
Verified
Book Chapter
Closed access
YLYanshu Li
Yanshu Li
ASAndreiv Sergee
Andreiv Sergee
NVNizami Vagidov
Nizami Vagidov
VMVladimir Mitin
Vladimir Mitin
KSKimberly Sablon
Kimberly Sablon